treatment options that were discordant. Patients with concordant choices were more likely to identify relief of symptoms as a factor (5) and family and friends as a source of information (4). Patients with discordant choices were more likely to value stone free rates (5).
INTRODUCTION AND OBJECTIVES:
The acute care surgery model was introduced to facilitate timely evaluation and treatment of patients presenting to the emergency room (ER) with acute conditions. While this model has been rapidly adopted in General Surgery, there is a paucity of data in Urology. We sought to examine the impact of our new Acute Care Urology (ACU) service on timeliness of care for acute stone patients. The ACU team consists of five rotating physicians on a daily basis who triage acute consults from the ER and inpatient wards at a large tertiary referral center.
METHODS: We conducted a retrospective review of all patients who underwent ureteral stent placement before (2012, pre-ACU) or after (2017, post-ACU) implementation of our ACU service. Only patients presenting to the ER and evaluated by the Urology team for an acute stone episode were included. Baseline demographic characteristics were recorded. The primary outcome was time from urological consult and/or stent placement to definitive stone intervention. Secondary outcomes included readmission rate (including repeat ER presentation) and lost to follow-up rate. Statistical analyses included Chi-Square, Cox proportional hazards model, and logistic regression with p<0.05 considered significant.
RESULTS: A total of 139 patients met inclusion criteria (68 pre-ACU, 71 post-ACU). Patient demographics were similar between both groups. On univariate analysis, time to definitive stone treatment was significantly shorter in the post-ACU group compared to the pre-ACU group (median 18.5 vs. 31.5 days, p[0.015). There were no statistically significant differences between pre-ACU and post-ACU groups in readmission (19.1% vs. 15.5%, p[0.70) or lost to follow-up rates (17.6% vs. 21.1%, p[0.76). On multivariate analysis including age, gender, insurance status, primary language (English vs. Non-English), and ACU status, only post-ACU status was associated with significantly shorter time to intervention (HR 1.55, 95% CI: 1.02-2.36, p[0.041). For readmission rate, only younger age was associated with higher readmission rates (OR 0.94, 95% CI: 0.90-0.98, p[0.004). There were no significant differences between patients lost to follow-up and those who returned.
CONCLUSIONS: Implementation of a dedicated ACU service decreased time to definitive stone treatment. Additionally, there was a clinically meaningful decrease in readmissions with an ACU service. Future studies are needed to evaluate its impact on healthcare costs, patient satisfaction, and other acute urological conditions amenable to this model.
Source of Funding: None

PD48-12 DEVELOPMENT AND VALIDATION OF THE CAMBRIDGE RENAL STONE PATIENT (CRESP) REPORTED OUTCOME MEASURE
Mostafa Ragab, Salisbury, United Kingdom; Jane Collie, Nikolay Baldin, Cambridge, United Kingdom; Maxine Tran, London, United Kingdom; James Armitage, Samih Al Hayek, Oliver Wiseman*, Cambridge, United Kingdom INTRODUCTION AND OBJECTIVES: Outcomes from surgery have traditionally been based on surgeon-reported outcomes. A paradigm shift in assessing healthcare productivity from output to qualitative outcome has led to increased interest in patient-reported outcome measures (PROMs). Our study describes the development and validation of the disease specific Cambridge renal stone PROM (CRESP).
METHODS: Patients with radiologically proven renal calculi who had undergone a range of management options were invited to participate in focus groups or semi-structured interviews, to elicit patient input and generation of CRESP content until reaching saturation. Validity studies included Cronbach's alpha for internal consistency, Spearman's and Pearson's correlation coefficients for test-retest reliability. Discriminant validity was assessed by Pearson's correlation versus EQ5D5L. Our project has Health and Social Care Research Ethics Committee approval.
RESULTS: A total of 86 patients participated in creating CRESP. 36 patients were invited to 22 semi-structured interviews and 4 focus groups. Major issues reported and themes selected for the PROM included pain, anxiety, limitations to social life and tiredness, urinary symptoms, dietary changes' impacts and gastrointestinal symptoms. Reliability analysis for 30 patients to determine internal consistency using Cronbach's alpha with a mean of 0.91 (range 0.90 to 0.93) and Cronbach's alpha between domains was 0.92. Average inter-item Pearson's and Spearman's correlation within domains was performed, with Pearson's correlation mean of 0.77 (range 0.73 to 0.85) and Spearman's correlation mean of 0.72 (range 0.63 to 0.77). Test-retest Pearson's correlation mean was 0.85 (range 0.57 to 0.95). Discriminant validity assessment was performed by comparing the averages of the scores of 2 groups of 40 patients and controls for each domain of CRESP, The mean scores of patients were systematically larger than the ones of control (Figure) . Pearson's correlation with EQ5D5L was -0.74, showing the newly developed CRESP successfully discriminated patients suffering from kidney stones.
CONCLUSIONS: Our validated patient-derived CRESP is a new instrument, specifically tailored to measure renal stone disease health outcomes from the patient's point of view.
